Debt-to-equity of Caribou Biosciences, Inc. from 31 Mar 2022 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Caribou Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2022 to 31 Dec 2025.
  • Caribou Biosciences, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 34%, a 60% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Caribou Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 34% +13% +60% 31 Dec 2025
Q3 2025 29% +9.5% +49% 30 Sep 2025
Q2 2025 26% +8% +46% 30 Jun 2025
Q1 2025 23% +3.5% +18% 31 Mar 2025
Q4 2024 21% +0.28% +1.3% 31 Dec 2024
Q3 2024 19% -3.2% -14% 30 Sep 2024
Q2 2024 18% -7.8% -31% 30 Jun 2024
Q1 2024 19% -3.9% -17% 31 Mar 2024
Q4 2023 21% -1.2% -5.6% 31 Dec 2023
Q3 2023 23% +3.2% +17% 30 Sep 2023
Q2 2023 25% +8.1% +47% 30 Jun 2023
Q1 2023 23% +1.5% +6.9% 31 Mar 2023
Q4 2022 22% 31 Dec 2022
Q3 2022 19% 30 Sep 2022
Q2 2022 17% 30 Jun 2022
Q1 2022 22% 31 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.